MAPS-Funded MDMA Therapy for PTSD Is Back at the FDA, Without a New Phase 3 Trial
MDMA assisted therapy for PTSD appears to be back in front of the FDA. Psychedelic Alpha reported on August 9
Read MoreB2B resources and operational guidance for ketamine and psychedelic clinic owners.
MDMA assisted therapy for PTSD appears to be back in front of the FDA. Psychedelic Alpha reported on August 9
Read More
The FDA's crackdown on compounded GLP-1 marketing is a preview for ketamine clinics. Your website copy may be your biggest
Read More
FDA cited Alar Pharmaceuticals over claims for an investigational ketamine product. The flagged phrases show up in a lot of
Read More
Ketamine clinics often pair medication with therapy, preparation, or integration. A new review asks whether psychotherapy adds measurable benefit for
Read More
ARPA-H's ASCENT-IBO program funds Phase 1 and 2 ibogaine trials for opioid use disorder, with patient safety up front. Solution
Read More
A healthcare-specific Google Maps playbook for ketamine clinics — GBP, citations, reviews, and the 5 generic SEO tactics to skip.
Read More
Editor’s note (September 16, 2026): DT120 has since cleared a third Phase 3 trial. We covered the Panorama results and
Read MoreWe see tons of ketamine clinic websites. While a lot of them look great, one little mistake can be the
Read More
Bipolar patients are routinely screened out of ketamine treatment over mania risk. A midazolam-controlled trial in JAMA Psychiatry finally tested
Read MoreThe FTC, Utah and California sued Hims & Hers over health data sharing, billing and cancellations. The practices named are
Read More